#GSK
articles
Personal Finance
Inside InvestingPro's September 2026 UK Stock Screen: Five Names to Test
Wise, GSK, MONY, Intermediate Capital and 3i Group make this month's FTSE 250 list. The data looks attractive—but the up...
Companies
Income Majors Under Review: Legal & General, GSK and Hill & Smith
A dividend-focused discussion weighs Legal & General's pensions pressure, GSK's £18bn R&D bet and Hill & Smith's US pivo...
Health
Trump's MMR Unbundling Order Would Mean Six Doctor Visits, New Vaccine Plants—and Little Legal Force
The executive order asks for separate measles, mumps and rubella shots within 90 days, but no standalone vaccines exist ...
Companies
Grifols Appoints Former GSK Executive to Board, Replacing Long-Serving Director
Joanna Le Couilliard, a seasoned pharma executive, joins Grifols as an independent director and audit committee chair, s...
Companies
GSK to Close Stevenage R&D Hub in £1.9bn Cost Drive, Opens Cambridge Flagship
The drugmaker will move 1,800 staff from its historic Stevenage centre to a new Cambridge site, launching a three-year c...